NCT03215901

Brief Summary

The mass provision of HIV treatment in rural KwaZulu-Natal, South Africa has raised adult life expectancy by 18 years since 2003. We will conduct a population-based survey to assess young adults' beliefs about HIV, HIV treatment, and expectations for the future in the era of mass HIV treatment. Thh investigators will conduct a randomized evaluation to assess whether a short video providing young adults with information on longevity gains from HIV treatment affects young adults survival expectations, hope for the future, and health and educational behaviours, including uptake of HIV testing, the study's primary outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
430

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 6, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 12, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

September 6, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2017

Completed
2.5 years until next milestone

Results Posted

Study results publicly available

June 17, 2020

Completed
Last Updated

June 17, 2020

Status Verified

September 1, 2018

Enrollment Period

3 months

First QC Date

July 6, 2017

Results QC Date

May 28, 2020

Last Update Submit

June 16, 2020

Conditions

Keywords

Population-based surveyHIV treatmentHIV testingSurvival expectationsCondom useLife plansSouth African young adults

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Who Participated in HIV Testing

    Participants were provided a voucher at baseline for free HIV testing at a private pharmacy in the area. This voucher could be used at any time within four weeks after baseline. Participants were also visited by an AHRI demographic and health surveillance team approximately six weeks after baseline during which all household members were offered a home-based rapid HIV test. This outcome takes the value of 1 if the participant used the HIV testing voucher OR participated in HIV testing during the household surveillance visit, and zero if the participant did not use the HIV testing voucher AND did not participate in HIV testing during the household surveillance visit.

    6 weeks

Secondary Outcomes (7)

  • Use of HIV Testing Voucher

    4 weeks

  • Participation in HIV Testing or Care Services

    3 months

  • Attendance at Job Search Skills Workshop

    2 weeks

  • Condoms Purchased

    Immediate post-test

  • Money Allocated to Savings Tin

    Immediate post-test

  • +2 more secondary outcomes

Study Arms (3)

A Beautiful Future Video

EXPERIMENTAL

Participants randomized to intervention will view intervention video.

Behavioral: A Beautiful Future Video

Active Control Video

SHAM COMPARATOR

Participants randomized to control will watch a video of similar length as the intervention video on a different topic.

Behavioral: Active Control Video

Pure Control

NO INTERVENTION

Participants view no video.

Interventions

Video delivering information on the longevity gains due to HIV treatment in the area.

A Beautiful Future Video

Video on another topic.

Active Control Video

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • resides in Africa Health Research Institute demographic surveillance area, specifically bounded structures to be visited during the last trimester of the surveillance in the "Southern PIPSA" area.
  • member of a household in the AHRI demographic surveillance
  • to 25 years of age

You may not qualify if:

  • \<18, \>25 years
  • not a member of a household under surveillance
  • not resident in the surveillance area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Africa Health Research Institute

Somkhele, KwaZulu-Natal, South Africa

Location

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeBehavior

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Results Point of Contact

Title
Jacob Bor, Assistant Professor
Organization
Boston University

Study Officials

  • Jacob Bor, SD

    Assistant Professor

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2017

First Posted

July 12, 2017

Study Start

September 6, 2017

Primary Completion

December 14, 2017

Study Completion

December 14, 2017

Last Updated

June 17, 2020

Results First Posted

June 17, 2020

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will share

De-identified data will be archived on the Africa Health Research Institute repository and will be available via a data request.

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be archived and publicly available within two years after data collection, and will be available indefinitely.
Access Criteria
Data use request to Africa Health Research Institute
More information

Locations